Pakistan Oxygen Limited (“POL” or “the company” - https://pakoxygen.com) is engaged in the manufacturing and sale of industrial and medical gases, manufacturing of welding electrodes and marketing of medical equipment. IFC is considering a loan of US$10.5 million to POL to build a modern and efficient 270-tpd ASU for production of oxygen, nitrogen and argon and to enhance production efficiencies at its Port Qasim plant (“the project”). As part of the proposed project, POL will also increase its storage facilities and upgrade the loading capacity to accommodate the additional products volumes.
ACCESS TO INFORMATION
You can submit a request for information disclosure at: https://disclosures.ifc.org/#/inquiries
If you believe that your request for information from IFC has been unreasonably denied, or that this Policy has been interpreted incorrectly, you can submit a complaint at the link above to IFC's Access to Information Policy Advisor, who reports directly to IFC's Executive Vice President.
ACCOUNTABILITY MECHANISM OF IFC/MIGA
The Compliance Advisor Ombudsman (CAO) is the independent complaint mechanism and fact-finding body for people who believe they are likely to be, or have been, adversely affected by an IFC or MIGA- financed project. If you submit a complaint to the CAO, they may assist you in resolving a dispute with the company and/or investigate to assess whether the IFC is following its own policies and procedures for preventing harm to people or the environment. If you want to submit a complaint electronically, you can email the CAO at CAO@worldbankgroup.org You can learn more about the CAO and how to file a complaint at http://www.cao-ombudsman.org